1. Scrip
  2. >>R&D

ISCR's Davis On Pandemic Adaptations, Value Of Multi-Regional Trials

Varying Implementation Of India's Trial Waiver Clause

 
• By Anju Ghangurde

The new chief of the Indian Society for Clinical Research, Sanish Davis, tells Scrip how the Indian trials segment coped amid pandemic upheaval, emphasizing the need for stakeholder “sensitization and socialization” of the concepts of virtual/hybrid trials as part of efforts to mainstream these. The executive also shared his views on India’s trial waiver clause.

Trials And Tribulations Amid COVID-19 • Source: Alamy

The Indian clinical trials sector, like many others, has had to navigate a turbulent 2020 as the pandemic forced a shift in traditional approaches to working amid lock-downs, challenges in patient mobility and re-purposing of clinical sites as COVID-19 care centers.

In a wide-ranging interview with Scrip, Dr Sanish Davis, incoming president of the Indian Society for Clinical Research (ISCR) and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Scrip

AstraZeneca Taps Into China’s R&D Engine With CSPC Alliance

 
• By Andrew McConaghie

After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.

Executives On The Move: New CMOs At Instil Bio, Nkarta & Catalyst Pharma

Recent moves in the industry include changes at the top at iOnctura and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.

In Brief: Starton Moves Low-Dose Lenalidomide To Phase IIa For Multiple Myeloma

 
• By Sushmita Panda

Study to add to safety and tolerability data for infused formulation and may help identify optimal dose for future pivotal trial.